2018 Q3 Form 10-K Financial Statement
#000114420418065134 Filed on December 18, 2018
Income Statement
| Concept | 2018 Q3 | 2018 Q2 | 2018 Q1 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $1.580M | $990.0K | $1.000M |
| YoY Change | 14.49% | -24.43% | -32.89% |
| % of Gross Profit | |||
| Research & Development | $650.0K | $634.0K | $1.014M |
| YoY Change | 30.0% | 18.59% | 42.9% |
| % of Gross Profit | |||
| Depreciation & Amortization | $10.00K | $1.706K | $1.130K |
| YoY Change | 376.54% | 216.53% | |
| % of Gross Profit | |||
| Operating Expenses | $2.230M | $1.620M | $2.014M |
| YoY Change | 18.62% | -12.0% | -8.63% |
| Operating Profit | -$2.233M | -$1.620M | -$2.014M |
| YoY Change | 18.71% | -12.0% | -8.63% |
| Interest Expense | $800.0K | $0.00 | $460.0K |
| YoY Change | -193.02% | 1615.46% | |
| % of Operating Profit | |||
| Other Income/Expense, Net | |||
| YoY Change | |||
| Pretax Income | -$1.440M | -$2.210M | -$1.560M |
| YoY Change | -47.45% | 24.16% | -16.58% |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$1.435M | -$2.213M | -$1.555M |
| YoY Change | -47.66% | 24.6% | -16.8% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | -$0.01 | ||
| Diluted Earnings Per Share | -$9.008K | -$14.68K | -$0.01 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 159.8M shares | 150.6M shares | 150.3M |
| Diluted Shares Outstanding | 159.8M shares | 150.6M shares | 150.3M |
Balance Sheet
| Concept | 2018 Q3 | 2018 Q2 | 2018 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $4.670M | $6.490M | $3.380M |
| YoY Change | -22.04% | 5.19% | -53.25% |
| Cash & Equivalents | $4.667M | $6.489M | $3.378M |
| Short-Term Investments | |||
| Other Short-Term Assets | $150.0K | $90.00K | $70.00K |
| YoY Change | 66.67% | -40.0% | -80.0% |
| Inventory | |||
| Prepaid Expenses | $151.8K | $87.73K | |
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $4.819M | $6.577M | $3.450M |
| YoY Change | -20.73% | 4.06% | -54.46% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $17.26K | $19.12K | $20.00K |
| YoY Change | 140.14% | 452.95% | 424.11% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $3.500K | $3.500K | $3.500K |
| YoY Change | 0.0% | ||
| Total Long-Term Assets | $20.76K | $22.62K | $20.00K |
| YoY Change | 94.25% | 554.16% | 424.11% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $4.819M | $6.577M | $3.450M |
| Total Long-Term Assets | $20.76K | $22.62K | $20.00K |
| Total Assets | $4.840M | $6.599M | $3.470M |
| YoY Change | -20.53% | 4.42% | -54.22% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $160.9K | $183.2K | $320.0K |
| YoY Change | -39.24% | -12.78% | 53.38% |
| Accrued Expenses | $130.0K | $180.0K | $70.00K |
| YoY Change | -23.53% | 12.5% | -53.33% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $288.4K | $358.8K | $390.0K |
| YoY Change | -33.48% | -3.11% | 7.5% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $3.190M | $3.990M | $1.000M |
| YoY Change | -7.0% | 55.25% | -61.98% |
| Total Long-Term Liabilities | $3.192M | $3.990M | $1.000M |
| YoY Change | -6.95% | 55.25% | -62.04% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $288.4K | $358.8K | $390.0K |
| Total Long-Term Liabilities | $3.192M | $3.990M | $1.000M |
| Total Liabilities | $3.480M | $4.349M | $1.390M |
| YoY Change | -9.92% | 47.92% | -53.63% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$34.32M | -$32.88M | |
| YoY Change | 16.32% | ||
| Common Stock | $35.68M | $33.00M | |
| YoY Change | 12.44% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $1.360M | $2.251M | $2.075M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $4.840M | $6.599M | $3.470M |
| YoY Change | -20.53% | 4.42% | -54.22% |
Cashflow Statement
| Concept | 2018 Q3 | 2018 Q2 | 2018 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$1.435M | -$2.213M | -$1.555M |
| YoY Change | -47.66% | 24.6% | -16.8% |
| Depreciation, Depletion And Amortization | $10.00K | $1.706K | $1.130K |
| YoY Change | 376.54% | 216.53% | |
| Cash From Operating Activities | -$1.820M | -$1.420M | -$1.570M |
| YoY Change | 47.97% | 44.9% | -22.66% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | -$10.00K | -$10.00K |
| YoY Change | -100.0% | ||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | $0.00 | -$10.00K | -$10.00K |
| YoY Change | -100.0% | ||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 0.000 | 4.540M | 0.000 |
| YoY Change | -100.0% | -5144.44% | -100.0% |
| NET CHANGE | |||
| Cash From Operating Activities | -1.820M | -1.420M | -1.570M |
| Cash From Investing Activities | 0.000 | -10.00K | -10.00K |
| Cash From Financing Activities | 0.000 | 4.540M | 0.000 |
| Net Change In Cash | -1.820M | 3.110M | -1.580M |
| YoY Change | 911.11% | -390.65% | -145.8% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$1.820M | -$1.420M | -$1.570M |
| Capital Expenditures | $0.00 | -$10.00K | -$10.00K |
| Free Cash Flow | -$1.820M | -$1.410M | -$1.560M |
| YoY Change | 49.18% | 43.88% | -23.15% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2018Q3 | us-gaap |
Cash
Cash
|
4667410 | USD |
| CY2017Q3 | us-gaap |
Cash
Cash
|
5994052 | USD |
| CY2018Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
151794 | USD |
| CY2017Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
85343 | USD |
| CY2018Q3 | us-gaap |
Assets Current
AssetsCurrent
|
4819204 | USD |
| CY2017Q3 | us-gaap |
Assets Current
AssetsCurrent
|
6079395 | USD |
| CY2018Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
17261 | USD |
| CY2017Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7188 | USD |
| CY2018Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3500 | USD |
| CY2017Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3500 | USD |
| CY2018Q3 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
20761 | USD |
| CY2017Q3 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
10688 | USD |
| CY2018Q3 | us-gaap |
Assets
Assets
|
4839965 | USD |
| CY2017Q3 | us-gaap |
Assets
Assets
|
6090083 | USD |
| CY2018Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
160946 | USD |
| CY2017Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
264876 | USD |
| CY2018Q3 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
127439 | USD |
| CY2017Q3 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
168655 | USD |
| CY2018Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
288385 | USD |
| CY2017Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
433531 | USD |
| CY2018Q3 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
3191752 | USD |
| CY2017Q3 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
3430033 | USD |
| CY2018Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
3191752 | USD |
| CY2017Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
3430033 | USD |
| CY2018Q3 | us-gaap |
Liabilities
Liabilities
|
3480137 | USD |
| CY2017Q3 | us-gaap |
Liabilities
Liabilities
|
3863564 | USD |
| CY2018Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2017Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2018Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
159815 | USD |
| CY2017Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
149943 | USD |
| CY2018Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
35517491 | USD |
| CY2017Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
31580022 | USD |
| CY2018Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-34317478 | USD |
| CY2017Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-29503446 | USD |
| CY2018Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1359828 | USD |
| CY2017Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2226519 | USD |
| CY2018Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4839965 | USD |
| CY2017Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6090083 | USD |
| CY2018 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2017 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2018 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4565522 | USD |
| CY2017 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5207753 | USD |
| CY2018 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2884245 | USD |
| CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2094795 | USD |
| CY2018 | us-gaap |
Operating Expenses
OperatingExpenses
|
7449767 | USD |
| CY2017 | us-gaap |
Operating Expenses
OperatingExpenses
|
7302548 | USD |
| CY2018 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7449767 | USD |
| CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7302548 | USD |
| CY2018 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
|
2635735 | USD |
| CY2017 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
|
-433923 | USD |
| CY2018 | us-gaap |
Interest Expense
InterestExpense
|
0 | USD |
| CY2017 | us-gaap |
Interest Expense
InterestExpense
|
52385 | USD |
| CY2018 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
2635735 | USD |
| CY2017 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-486308 | USD |
| CY2018 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | |
| CY2017 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.05 | |
| CY2018 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
152712714 | shares |
| CY2017 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
142722788 | shares |
| CY2017Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5994052 | USD |
| CY2016Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5036476 | USD |
| CY2018Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4667410 | USD |
| CY2018 | us-gaap |
Stock Issued1
StockIssued1
|
117 | USD |
| CY2017 | us-gaap |
Stock Issued1
StockIssued1
|
107 | USD |
| CY2018 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
2397454 | USD |
| CY2017 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
2996110 | USD |
| CY2018 | arth |
Stock Issued During Period Value Restricted Stock Vested
StockIssuedDuringPeriodValueRestrictedStockVested
|
233 | USD |
| CY2017 | arth |
Stock Issued During Period Value Restricted Stock Vested
StockIssuedDuringPeriodValueRestrictedStockVested
|
0 | USD |
| CY2018 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
| CY2017 | us-gaap |
Interest Paid Net
InterestPaidNet
|
361268 | USD |
| CY2018Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
28026 | USD |
| CY2017Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
12611 | USD |
| CY2018Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets
|
10765 | USD |
| CY2017Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets
|
5423 | USD |
| CY2018Q4 | arth |
Increase In Aggregate Number Of Shares
IncreaseInAggregateNumberOfShares
|
3000000 | shares |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.9315 | pure |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.1944 | pure |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0131 | pure |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0285 | pure |
| CY2018 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
|
0 | pure |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y3M | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
14634210 | shares |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2605000 | shares |
| CY2018 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
435000 | shares |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
1120000 | shares |
| CY2018Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
15684210 | shares |
| CY2018Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
15684210 | shares |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.39 | |
| CY2018 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.45 | |
| CY2018 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.37 | |
| CY2018 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.42 | |
| CY2018Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.41 | |
| CY2018Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
0.40 | |
| CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y8M19D | |
| CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P3Y10M20D | |
| CY2018Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
1142521 | USD |
| CY2018Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
1878980 | shares |
| CY2018Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
754000 | USD |
| CY2018Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
745000 | shares |
| CY2018Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
|
1 | pure |
| CY2018Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
100000 | shares |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
1750000 | shares |
| CY2017Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
|
1 | pure |
| CY2016Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
225000 | shares |
| CY2016Q3 | us-gaap |
Share Price
SharePrice
|
0.72 | |
| CY2016Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
|
375000 | shares |
| CY2017Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
0 | USD |
| CY2014Q4 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
224000 | USD |
| CY2015Q1 | arth |
Gain Loss On Warrant Derivative Modification
GainLossOnWarrantDerivativeModification
|
624016 | USD |
| CY2015Q2 | us-gaap |
Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
|
3263753 | USD |
| CY2017Q1 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
2996110 | USD |
| CY2018Q3 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
2397454 | USD |
| CY2018Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2018Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
| CY2018Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
164397013 | shares |
| CY2017Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
| CY2016Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3160995 | USD |
| CY2017 | arth |
Stock Issued During Period Value Restricted Stock For Services
StockIssuedDuringPeriodValueRestrictedStockForServices
|
162000 | USD |
| CY2017 | arth |
Stock Issued During Period Value Warants Exercised
StockIssuedDuringPeriodValueWarantsExercised
|
1589888 | USD |
| CY2017 | arth |
Stock Issued During Period Value Cash Less Stock Options Exercised One
StockIssuedDuringPeriodValueCashLessStockOptionsExercisedOne
|
5500 | USD |
| CY2017 | arth |
Stock Issued During Period Value Cash Less Stock Options Exercised Two
StockIssuedDuringPeriodValueCashLessStockOptionsExercisedTwo
|
0 | USD |
| CY2017 | arth |
Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
|
0 | USD |
| CY2017 | arth |
Stock Issued During Period Value Private Placement Funding
StockIssuedDuringPeriodValuePrivatePlacementFunding
|
2991012 | USD |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2105980 | USD |
| CY2018 | arth |
Stock Issued During Period Value Warants Exercised
StockIssuedDuringPeriodValueWarantsExercised
|
63388 | USD |
| CY2018 | arth |
Stock Issued During Period Value Cash Less Stock Options Exercised Two
StockIssuedDuringPeriodValueCashLessStockOptionsExercisedTwo
|
0 | USD |
| CY2018 | arth |
Stock Issued During Period Value Cash Less Stock Options Exercised One
StockIssuedDuringPeriodValueCashLessStockOptionsExercisedOne
|
77700 | USD |
| CY2018 | arth |
Stock Issued During Period Value Private Placement Funding
StockIssuedDuringPeriodValuePrivatePlacementFunding
|
2063794 | USD |
| CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1742459 | USD |
| CY2018 | us-gaap |
Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
|
<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Derivative Liabilities</div></div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its warrants and other derivative financial instruments as either equity or liabilities based upon the characteristics and provisions of each instrument, in accordance with FASB ASC Topic 815, Derivatives and Hedging. Warrants classified as equity are recorded at fair value as of the date of issuance on the Company’s consolidated balance sheets and no further adjustments to their valuation are made. Warrants classified as derivative liabilities and other derivative financial instruments that require separate accounting as liabilities are recorded on the Company’s consolidated balance sheets at their fair value on the date of issuance and will be revalued on each subsequent balance sheet date until such instruments are exercised or expire, with any changes in the fair value between reporting periods recorded as other income or expense. Management estimates the fair value of these liabilities using option pricing models and assumptions that are based on the individual characteristics of the warrants or instruments on the valuation date, as well as assumptions for future financings, expected volatility, expected life, yield, and risk-free interest rate.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2018 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Concentration of Credit Risk</div></div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash. The Company maintains its cash in bank deposits accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2018Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
5848080 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
7129736 | USD |
| CY2018Q3 | arth |
Deferred Tax Assets Capitalized Expenditures
DeferredTaxAssetsCapitalizedExpenditures
|
1486679 | USD |
| CY2017Q3 | arth |
Deferred Tax Assets Capitalized Expenditures
DeferredTaxAssetsCapitalizedExpenditures
|
1511187 | USD |
| CY2018Q3 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
802765 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
632659 | USD |
| CY2018Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2074247 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2370477 | USD |
| CY2018Q3 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
|
1235 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
|
1488 | USD |
| CY2018Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
13660 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
20100 | USD |
| CY2018Q3 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
10226994 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
11665647 | USD |
| CY2018Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
10226994 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
11665647 | USD |
| CY2018Q3 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2018Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
21770000 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
17960000 | USD |
| CY2018Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
20730000 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
16771000 | USD |
| CY2017 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
3041000 | USD |
| CY2018 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1440000 | USD |
| CY2018Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
|
328 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
|
0 | USD |
| CY2018 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.21 | pure |
| CY2016Q3 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
3400000 | shares |
| CY2018 | us-gaap |
Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
|
The loan originally bore interest at a rate of 10% per annum, and was originally scheduled to become fully due and payable on the earlier of (i) September 30, 2018, (ii) the occurrence of an event of default under the MLSC Loan Agreement, or (iii) the completion of a sale of substantially all of our assets, a change-of-control transaction (“Qualified Sale”) or one or more financing transactions in which we receive from third parties other than our then existing shareholders net proceeds of $5,000,000 or more in a 12-month period | |
| CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
12703439 | shares |
| CY2018 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
|
0.39 | |
| CY2018 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTerm
|
P4Y3M | |
| CY2018 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodAggregateIntrinsicValue
|
1123133 | USD |
| CY2018 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Awarded Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAwardedWeightedAverageRemainingContractualTerm
|
P0Y | |
| CY2018 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
|
P0Y | |
| CY2018 | arth |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm
|
P0Y | |
| CY2018 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1326642 | USD |
| CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
957576 | USD |
| CY2018 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5913563 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5616248 | USD |
| CY2018 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-15415 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-8686 | USD |
| CY2018 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4602336 | USD |
| CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
6582510 | USD |
| CY2018 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4814032 | USD |
| CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7788856 | USD |
| CY2018 | us-gaap |
Depreciation
Depreciation
|
5342 | USD |
| CY2017 | us-gaap |
Depreciation
Depreciation
|
1498 | USD |
| CY2018 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1742459 | USD |
| CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2105980 | USD |
| CY2018 | arth |
Noncash Interest Expense On Notes Payable
NoncashInterestExpenseOnNotesPayable
|
0 | USD |
| CY2017 | arth |
Noncash Interest Expense On Notes Payable
NoncashInterestExpenseOnNotesPayable
|
22118 | USD |
| CY2018 | us-gaap |
Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
|
0 | USD |
| CY2017 | us-gaap |
Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
|
-162000 | USD |
| CY2018 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
-2635735 | USD |
| CY2017 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
433923 | USD |
| CY2018 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
66451 | USD |
| CY2017 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-22441 | USD |
| CY2018 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | USD |
| CY2017 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
3500 | USD |
| CY2018 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-103930 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-110020 | USD |
| CY2018 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-41216 | USD |
| CY2017 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-130832 | USD |
| CY2018 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD |
| CY2017 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-331000 | USD |
| CY2018 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
15415 | USD |
| CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
8686 | USD |
| CY2018 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
63388 | USD |
| CY2017 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
1589888 | USD |
| CY2018 | arth |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
4461248 | USD |
| CY2017 | arth |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
5987122 | USD |
| CY2018 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
77700 | USD |
| CY2017 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
5500 | USD |
| CY2018 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
| CY2017 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1000000 | USD |
| CY2018Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
164397013 | shares |
| CY2017Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
153692857 | shares |
| CY2017Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
153692857 | shares |
| CY2018 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Use of Estimates</div></div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: "times new roman", serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017Q1 | arth |
Fair Values Assumptions Expected Dividend Rates
FairValuesAssumptionsExpectedDividendRates
|
0 | pure |
| CY2018 | arth |
Stock Issued During Period Value Restricted Stock For Services
StockIssuedDuringPeriodValueRestrictedStockForServices
|
0 | USD |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
6178263 | USD |
| CY2018Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1142521 | USD |
| CY2017Q4 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2018Q1 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2018Q2 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2018Q3 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2017Q4 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
| CY2018Q1 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
| CY2018Q2 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
| CY2018Q3 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
| CY2017Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1582373 | USD |
| CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2013845 | USD |
| CY2018Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1620134 | USD |
| CY2018Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2233415 | USD |
| CY2017Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
389176 | USD |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1555361 | USD |
| CY2018Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2212640 | USD |
| CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1435207 | USD |
| CY2017Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
| CY2018Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
| CY2018Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
| CY2017Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
150144575 | shares |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
150302013 | shares |
| CY2018Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
150550189 | shares |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
159778165 | shares |
| CY2017Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
163527032 | shares |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
150302013 | shares |
| CY2018Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
150550189 | shares |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
159778165 | shares |
| CY2016Q4 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2017Q1 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2017Q2 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2017Q3 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2016Q4 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
| CY2017Q1 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
| CY2017Q2 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
| CY2017Q3 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
| CY2016Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1375931 | USD |
| CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2204123 | USD |
| CY2017Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1841066 | USD |
| CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1881428 | USD |
| CY2016Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1401501 | USD |
| CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1869432 | USD |
| CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1775740 | USD |
| CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2742183 | USD |
| CY2016Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
| CY2017Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.02 | |
| CY2016Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
135319847 | shares |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
140513488 | shares |
| CY2017Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
147019042 | shares |
| CY2017Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
147989550 | shares |
| CY2018 | dei |
Document Type
DocumentType
|
10-K | |
| CY2018 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2018 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-09-30 | |
| CY2018 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2018 | |
| CY2018 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2018 | dei |
Entity Registrant Name
EntityRegistrantName
|
Arch Therapeutics, Inc. | |
| CY2018 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001537561 | |
| CY2018 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--09-30 | |
| CY2018 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2018 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2018 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2018 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
| CY2018Q1 | dei |
Entity Public Float
EntityPublicFloat
|
42000000 | USD |
| CY2018 | dei |
Trading Symbol
TradingSymbol
|
ARTH | |
| CY2018Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
164441786 | shares |
| CY2018 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2018 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
| CY2018 | dei |
Entity Small Business
EntitySmallBusiness
|
true |
